Ernie Richardsen
Ernie Richardsen is Senior Vice President, Head of U.S. Commercial Generics for Teva Pharmaceuticals, where he is responsible for all U.S. Generics Commercial activities. Ernie first joined Teva in 2020 as President of Anda, Inc. Ernie has over 32 years of industry experience which, in addition to Teva and Anda, has included leadership positions at […]
Aman Trehan
Aman Trehan, Ph.D. is the Chief Growth Officer of Somerset Therapeutics/Pharma LLC. He is responsible for overseeing all activities related to the company’s product portfolio—including product selection and product strategy, business development and licensing deals, intellectual property – including patent portfolio, patent strategies and Hatch Waxman litigations – and coordinating R&D projects. Dr. Trehan has […]
Arunesh Verma
Arunesh Verma is President of Fresenius Kabi in the United States and a member of the company’s global Executive Leadership Team. Fresenius Kabi is a leading U.S. developer and manufacturer of injectable medicines and biosimilars. Arun has deep experience in essential medicines with past roles of increasing responsibility at Cipla where he was CEO of […]
Maryll Toufanian
Maryll Toufanian is Senior Vice President, Regulatory Strategy and Government Affairs, at Amneal Pharmaceuticals Inc., where she leads the company’s efforts to develop top-level regulatory strategies. She also leads Amneal’s government relations and public policy interface with state and federal policymakers. Prior to Amneal, Maryll held senior leadership roles at the FDA and served as […]
Brandon Rockwell
Brandon Rockwell is Chief Operating Officer at PAI Pharma where he is responsible for PAI’s Growth Strategy. At PAI, he has responsibility for various functions in the organization including R&D, Regulatory, Business Development, Project / Alliance Management and Operations. Brandon has over 15 years of Pharma experience and has held various areas of responsibilities in […]
Punit Patel
Punit Patel is the President and Chief Executive Officer, Americas, Zydus Group. He is responsible for the business operations of all Zydus entities in North America which include generics, injectables and specialty business, rare and orphan disease portfolio and also future forays into novel therapeutics. Punit has more than 20 years of experience in the generics […]
Paul McMahon
Paul McMahon is President, Commercial Operations, at Aurobindo Pharma USA, Inc. He joined Aurobindo in 2009 as Director, National Accounts and has held roles with increased responsibility during his tenure. Prior to joining Aurobindo, Paul worked at Barr Labs and Taro Pharmaceuticals. Paul holds a BA from State University of New York at Binghamton.
Emily King
Emily M. King serves as General Counsel and Vice President of Accord Healthcare, Inc., serving as a strategic partner to business unit leaders internally and with partners, customers and vendors worldwide. Accord Healthcare is a wholly-owned subsidiary of Intas Pharmaceuticals, Limited, a pharmaceutical company with a footprint in 85 countries that focuses on oncology products. As […]
Marc Kikuchi
Marc Kikuchi is the President and Business Head of North America at Glenmark Pharmaceuticals Incorporated. He is responsible for operations, and strategic and growth portfolio of the company in the region. Spanning over three decades, Marc has held multiple and diverse roles of increasing responsibility. Prior to joining Glenmark in 2024, he worked with Dr. Reddy’s […]
Milan Kalawadia
Milan Kalawadia is the Chief Executive Officer, North America at Dr. Reddy’s Laboratories Inc. He is responsible for leading the North America business and serves as a member of the Board of Dr. Reddy’s Laboratories, Inc. Milan has more than 19 years of experience in the pharmaceutical marketplace. He has been with Dr. Reddy’s since 2006. […]
Bob Hoffman (Vice Chair)
Bob Hoffman is AAM Vice Chair and Chief Commercial Officer of US Generics for Lupin Pharmaceuticals, Inc. In this role, he is responsible for executing the strategic direction of the business and all of the Commercial Operations functions. He has been with Lupin since 2005 and has over 31 years of experience in the pharmaceutical industry. […]
Keren Haruvi (Chair)
Keren Haruvi is AAM Board Chair and President of Sandoz North America. In her role at Sandoz, she leads Sandoz’s largest commercial and country organization – the United States – which is responsible for approximately a quarter of the global revenue for Sandoz Inc. She also oversees Sandoz commercial operations in Canada, and is a member […]
